BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19527713)

  • 1. Bleomycin-induced over-replication involves sustained inhibition of mitotic entry through the ATM/ATR pathway.
    Nakayama Y; Igarashi A; Kikuchi I; Obata Y; Fukumoto Y; Yamaguchi N
    Exp Cell Res; 2009 Sep; 315(15):2515-28. PubMed ID: 19527713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATM/ATR-independent inhibition of cyclin B accumulation in response to hydroxyurea in nontransformed cell lines is altered in tumour cell lines.
    Florensa R; Bachs O; Agell N
    Oncogene; 2003 Nov; 22(51):8283-92. PubMed ID: 14614452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.
    Castedo M; Perfettini JL; Roumier T; Yakushijin K; Horne D; Medema R; Kroemer G
    Oncogene; 2004 May; 23(25):4353-61. PubMed ID: 15048074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ERK-RSK1 activation by growth factors at G2 phase delays cell cycle progression and reduces mitotic aberrations.
    Nam HJ; Kim S; Lee MW; Lee BS; Hara T; Saya H; Cho H; Lee JH
    Cell Signal; 2008 Jul; 20(7):1349-58. PubMed ID: 18450423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms underlying the pro-survival pathway of p53 in suppressing mitotic death induced by adriamycin.
    Lin YC; Wang FF
    Cell Signal; 2008 Jan; 20(1):258-67. PubMed ID: 18006273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.
    Zimmermann M; Arachchige-Don AS; Donaldson MS; Dallapiazza RF; Cowan CE; Horne MC
    J Biol Chem; 2012 Jun; 287(27):22838-53. PubMed ID: 22589537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
    Yuan JH; Feng Y; Fisher RH; Maloid S; Longo DL; Ferris DK
    Mol Cancer Res; 2004 Jul; 2(7):417-26. PubMed ID: 15280449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chk1- and claspin-dependent but ATR/ATM- and Rad17-independent DNA replication checkpoint response in HeLa cells.
    Rodríguez-Bravo V; Guaita-Esteruelas S; Florensa R; Bachs O; Agell N
    Cancer Res; 2006 Sep; 66(17):8672-9. PubMed ID: 16951182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM/ATR-related checkpoint signals mediate arsenite-induced G2/M arrest in primary aortic endothelial cells.
    Tsou TC; Tsai FY; Yeh SC; Chang LW
    Arch Toxicol; 2006 Dec; 80(12):804-10. PubMed ID: 16645841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1.
    Park I; Avraham HK
    Exp Cell Res; 2006 Jul; 312(11):1996-2008. PubMed ID: 16630610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
    Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
    Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.
    Lee HJ; Hwang HI; Jang YJ
    Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF inhibits the activity of the cyclin B1/CDK1 kinase to induce a transient G₂arrest in RCS chondrocytes.
    Tran T; Kolupaeva V; Basilico C
    Cell Cycle; 2010 Nov; 9(21):4379-86. PubMed ID: 21051949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of S-phase progression triggered by UVA-induced ROS does not require a functional DNA damage checkpoint response in mammalian cells.
    Girard PM; Pozzebon M; Delacôte F; Douki T; Smirnova V; Sage E
    DNA Repair (Amst); 2008 Sep; 7(9):1500-16. PubMed ID: 18603484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cisplatin-induced ATR activity and enhanced sensitivity to cisplatin.
    Yazlovitskaya EM; Persons DL
    Anticancer Res; 2003; 23(3B):2275-9. PubMed ID: 12894503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase.
    Kruyt FA; Dijkmans LM; Arwert F; Joenje H
    Cancer Res; 1997 Jun; 57(11):2244-51. PubMed ID: 9187128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation.
    Wei F; Xie Y; Tao L; Tang D
    Cell Signal; 2010 Nov; 22(11):1783-9. PubMed ID: 20637859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cyclin B1 levels in DNA damage and DNA damage-induced senescence.
    Nakayama Y; Yamaguchi N
    Int Rev Cell Mol Biol; 2013; 305():303-37. PubMed ID: 23890385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1.
    Nomura N; Nomura M; Newcomb EW; Zagzag D
    Biochem Pharmacol; 2007 May; 73(10):1528-36. PubMed ID: 17324379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.